
Ann Hammarstedt
Articles
-
Dec 7, 2023 |
ahajournals.org | John McMurray |Kieran F. Docherty |Ann Hammarstedt |Dalane W. Kitzman
BACKGROUND:Sodium-glucose cotransporter 2 inhibitors reduce the risk of worsening heart failure (HF) and cardiovascular death in patients with HF irrespective of left ventricular ejection fraction. It is important to determine whether therapies for HF improve symptoms and functional capacity.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →